70 related articles for article (PubMed ID: 17693625)
1. ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity.
Liz MA; Gomes CM; Saraiva MJ; Sousa MM
J Lipid Res; 2007 Nov; 48(11):2385-95. PubMed ID: 17693625
[TBL] [Abstract][Full Text] [Related]
2. ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future.
Kalayci A; Gibson CM; Ridker PM; Wright SD; Kingwell BA; Korjian S; Chi G; Lee JJ; Tricoci P; Kazmi SH; Fitzgerald C; Shaunik A; Berman G; Duffy D; Libby P
Curr Atheroscler Rep; 2022 Jul; 24(7):585-597. PubMed ID: 35524914
[TBL] [Abstract][Full Text] [Related]
3. Conformational flexibility of apolipoprotein A-I amino- and carboxy-termini is necessary for lipid binding but not cholesterol efflux.
Bedi S; Morris J; Shah A; Hart RC; Jerome WG; Aller SG; Tang C; Vaisar T; Bornfeldt KE; Segrest JP; Heinecke JW; Davidson WS
J Lipid Res; 2022 Mar; 63(3):100168. PubMed ID: 35051413
[TBL] [Abstract][Full Text] [Related]
4. Structure dynamics of ApoA-I amyloidogenic variants in small HDL increase their ability to mediate cholesterol efflux.
Nilsson O; Lindvall M; Obici L; Ekström S; Lagerstedt JO; Del Giudice R
J Lipid Res; 2021; 62():100004. PubMed ID: 33410751
[TBL] [Abstract][Full Text] [Related]
5. Insights into the Structural Basis of Amyloid Resistance Provided by Cryo-EM Structures of AApoAII Amyloid Fibrils.
Andreotti G; Baur J; Ugrina M; Pfeiffer PB; Hartmann M; Wiese S; Miyahara H; Higuchi K; Schwierz N; Schmidt M; Fändrich M
J Mol Biol; 2024 Feb; 436(4):168441. PubMed ID: 38199491
[TBL] [Abstract][Full Text] [Related]
6. Identification of isoaspartate-modified transthyretin as potential target for selective immunotherapy of transthyretin amyloidosis.
Köppen J; Kleinschmidt M; Morawski M; Rahfeld JU; Wermann M; Cynis H; Hegenbart U; Daniel C; Roßner S; Schilling S; Schulze A
Amyloid; 2024 May; ():1-11. PubMed ID: 38801321
[TBL] [Abstract][Full Text] [Related]
7. High-efficient bacterial production of human ApoA-I amyloidogenic variants.
Del Giudice R; Lagerstedt JO
Protein Sci; 2018 Dec; 27(12):2101-2109. PubMed ID: 30291643
[TBL] [Abstract][Full Text] [Related]
8. Amyloidogenic 60-71 deletion/ValThr insertion mutation of apolipoprotein A-I generates a new aggregation-prone segment that promotes nucleation through entropic effects.
Namba N; Ohgita T; Tamagaki-Asahina H; Nishitsuji K; Shimanouchi T; Sato T; Saito H
Sci Rep; 2023 Oct; 13(1):18514. PubMed ID: 37898709
[TBL] [Abstract][Full Text] [Related]
9. Degradation versus fibrillogenesis, two alternative pathways modulated by seeds and glycosaminoglycans.
Verona G; Raimondi S; Canetti D; Mangione PP; Marchese L; Corazza A; Lavatelli F; Gillmore JD; Taylor GW; Bellotti V; Giorgetti S
Protein Sci; 2024 Mar; 33(3):e4931. PubMed ID: 38380705
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Anti-Inflammatory Activity of Lipid-Free Apolipoprotein (apo) A-I and CIGB-258 in Acute-Phase Zebrafish via Stabilization of the apoA-I Structure to Enhance Anti-Glycation and Antioxidant Activities.
Cho KH; Bahuguna A; Lee Y; Lee SH; Dominguez-Horta MDC; Martinez-Donato G
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791598
[TBL] [Abstract][Full Text] [Related]
11. Proteomics analysis of coronary atherosclerotic heart disease with different Traditional Chinese Medicine syndrome types before and after percutaneous coronary intervention.
Zhibo W; Ying LI; Daoping W; Bo MA; Lan M; Junguo R; Jinghua L; Jianxun L
J Tradit Chin Med; 2024 Jun; 44(3):554-563. PubMed ID: 38767640
[TBL] [Abstract][Full Text] [Related]
12. Lipoproteins and Calcific Aortic Valve Disease: Hardening Evidence?
O'Brien KD
Arterioscler Thromb Vasc Biol; 2022 Nov; 42(11):1321-1323. PubMed ID: 36134565
[No Abstract] [Full Text] [Related]
13. The integration of genetically-regulated transcriptomics and electronic health records highlights a pattern of medical outcomes related to increased hepatic
Pathak GA; De Lillo A; Wendt FR; De Angelis F; Koller D; Cabrera Mendoza B; Jacoby D; Miller EJ; Buxbaum JN; Polimanti R
Amyloid; 2022 Jun; 29(2):110-119. PubMed ID: 34935565
[TBL] [Abstract][Full Text] [Related]
14. N-Terminomics Strategies for Protease Substrates Profiling.
Mintoo M; Chakravarty A; Tilvawala R
Molecules; 2021 Aug; 26(15):. PubMed ID: 34361849
[TBL] [Abstract][Full Text] [Related]
15. Transthyretin: From Structural Stability to Osteoarticular and Cardiovascular Diseases.
Wieczorek E; Ożyhar A
Cells; 2021 Jul; 10(7):. PubMed ID: 34359938
[TBL] [Abstract][Full Text] [Related]
16. The role of transthyretin in cell biology: impact on human pathophysiology.
Magalhães J; Eira J; Liz MA
Cell Mol Life Sci; 2021 Sep; 78(17-18):6105-6117. PubMed ID: 34297165
[TBL] [Abstract][Full Text] [Related]
17. The interaction of zinc with the multi-functional plasma thyroid hormone distributor protein, transthyretin: evolutionary and cross-species comparative aspects.
Yamauchi K
Biometals; 2021 Jun; 34(3):423-437. PubMed ID: 33686575
[TBL] [Abstract][Full Text] [Related]
18. Plasma Proteome Profiling of Coronary Artery Disease Patients: Downregulation of Transthyretin-An Important Event.
Monu ; Kharb R; Sharma A; Chaddar MK; Yadav R; Agnihotri P; Kar A; Biswas S
Mediators Inflamm; 2020; 2020():3429541. PubMed ID: 33299376
[TBL] [Abstract][Full Text] [Related]
19. Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer's Disease?
Saponaro F; Kim JH; Chiellini G
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212973
[TBL] [Abstract][Full Text] [Related]
20. Association between transthyretin concentrations and gestational diabetes mellitus in Chinese women.
Liu M; Chen Y; Chen D
Arch Gynecol Obstet; 2020 Aug; 302(2):329-335. PubMed ID: 32451658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
